This article explores leading stem cell centers within the U.S. and worldwide. Read on to learn about this emerging area of medicine. [Read more…]
GIOSTAR Reports on a Positive Outcome of a COVID-19 Patient After Stem Cell Treatment
Promising results point to a potential alternative in combating the pandemic
San Diego, July 28, 2020 — Global Institute of Stem Cell Therapy and Research (GIOSTAR), the worldwide leader in stem cell research, is pleased to announce the outcome of a COVID-19 patient treated using stem cells. Led by Chairman and Co-Founder Dr. Anand Srivastava, GIOSTAR received approval for the treatment under the U.S. Food and Drug Administration (FDA) “expanded access for compassionate use” program. As of July 14, 2020, there have been more than 13 million COVID-19 cases and over 500,000 deaths worldwide. [Read more…]
Critically Ill COVID-19 Patient Successfully Treated with Vitro Biopharma’s AlloRx Stem Cells(R)
GOLDEN, CO July 14, 2020 — Vitro Diagnostics, Inc. (OTC PINK:VODG), dba Vitro Biopharma, jointly with GIOSTAR – a San Diego, California-based institution headed by Dr. Anand Srivastava, a pioneer in stem cell science – announced the results of treatment of a critically ill COVID-19 patient with its lead clinical product AlloRx Stem Cells®. [Read more…]
GIOSTAR Chicago Unveils LipoRe
Location is one of the first centers in the world to offer awake liposuction and rejuvenation in one short visit
CHICAGO, June 18, 2019 — GIOSTAR Chicago, the leader in regenerative technologies, today announced the launch of LipoRe – a “one-stop shop” for total body rejuvenation and cosmetic fat reduction. [Read more…]
